Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
CALL
Scorpio Tankers
STNG
$3.98B
| $2.17M | ﹤0.01% |
169,100
-319,500
| -65% | -$5.79M |
|
4252
Harmony Gold Mining
HMY
$12.1B
| $2.16M | ﹤0.01% |
518,864
+352,544
| +212% | +$1.16M |
|
|
SIOX
4253
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $2.16M | ﹤0.01% |
767,416
-87,855
| -10% | -$282K |
|
|
KBAL
4254
DELISTED
Kimball International
KBAL
| $2.16M | ﹤0.01% |
187,084
+92,428
| +98% | +$1.06M |
|
|
CLVS
4255
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.16M | ﹤0.01% |
320,300
-89,900
| -22% | -$681K |
|
4256
Medifast
MED
$128M
| $2.16M | ﹤0.01% |
15,576
-21,436
| -58% | -$1.97M |
|
4257
CALL
10x Genomics
TXG
$7.31B
| $2.16M | ﹤0.01% |
24,200
-6,300
| -21% | -$491K |
|
|
XEC
4258
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $2.16M | ﹤0.01% |
78,600
-10,800
| -12% | -$268K |
|
4259
PUT
Franklin Resources
BEN
$17.2B
| $2.16M | ﹤0.01% |
103,000
-29,300
| -22% | -$553K |
|
|
VBTX
4260
DELISTED
Veritex Holdings
VBTX
| $2.16M | ﹤0.01% |
122,010
-58,320
| -32% | -$947K |
|
4261
G-III Apparel Group
GIII
$1.43B
| $2.16M | ﹤0.01% |
162,488
-515,201
| -76% | -$5.69M |
|
|
PDM
4262
Piedmont Realty Trust
PDM
$1.19B
| $2.16M | ﹤0.01% |
129,920
-143,768
| -53% | -$2.4M |
|
|
SNBR
4263
CALL
DELISTED
Sleep Number
SNBR
| $2.16M | ﹤0.01% |
51,800
+23,900
| +86% | +$760K |
|
4264
PUT
National Health Investors
NHI
$3.58B
| $2.16M | ﹤0.01% |
35,500
+10,500
| +42% | +$577K |
|
|
BSTC
4265
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.15M | ﹤0.01% |
35,176
+5,117
| +17% | +$296K |
|
4266
CALL
Cannae Holdings
CNNE
$635M
| $2.15M | ﹤0.01% |
52,400
+35,800
| +216% | +$1.22M |
|
|
ADAP
4267
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.15M | ﹤0.01% |
215,100
+188,500
| +709% | +$1.18M |
|
4268
Enanta Pharmaceuticals
ENTA
$383M
| $2.15M | ﹤0.01% |
42,885
-89,608
| -68% | -$4.64M |
|
4269
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$269M
| $2.15M | ﹤0.01% |
+46,075
| New | +$1.78M |
|
4270
Magnite
MGNI
$3.55B
| $2.15M | ﹤0.01% |
322,473
-79,301
| -20% | -$495K |
|
4271
ADT
ADT
$5.47B
| $2.15M | ﹤0.01% |
269,381
+255,324
| +1,816% | +$1.65M |
|
4272
CALL
Ashland
ASH
$3.38B
| $2.15M | ﹤0.01% |
31,100
-6,200
| -17% | -$385K |
|
|
CHIX
4273
DELISTED
Global X MSCI China Financials ETF
CHIX
| $2.15M | ﹤0.01% |
155,986
+22,638
| +17% | +$311K |
|
4274
CALL
AMC Entertainment Holdings
AMC
$2.23B
| $2.15M | ﹤0.01% |
50,060
+3,160
| +7% | +$138K |
|
4275
Compañía de Minas Buenaventura
BVN
$8.57B
| $2.15M | ﹤0.01% |
+234,972
| New | +$1.9M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.